166 related articles for article (PubMed ID: 10503184)
1. Endothelin-1 levels in infants with pulmonary hypertension receiving extracorporeal membrane oxygenation.
Macdonald PD; Paton RD; Logan RW; Skeoch CH; Davis CF
J Perinat Med; 1999; 27(3):216-20. PubMed ID: 10503184
[TBL] [Abstract][Full Text] [Related]
2. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn.
Kumar P; Kazzi NJ; Shankaran S
Am J Perinatol; 1996 Aug; 13(6):335-41. PubMed ID: 8865978
[TBL] [Abstract][Full Text] [Related]
3. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation.
Dollberg S; Warner BW; Myatt L
Pediatr Res; 1995 Jan; 37(1):31-4. PubMed ID: 7700731
[TBL] [Abstract][Full Text] [Related]
4. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension.
Rosenberg AA; Kennaugh J; Koppenhafer SL; Loomis M; Chatfield BA; Abman SH
J Pediatr; 1993 Jul; 123(1):109-14. PubMed ID: 8320603
[TBL] [Abstract][Full Text] [Related]
5. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
Reynolds EW; Ellington JG; Vranicar M; Bada HS
Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
[TBL] [Abstract][Full Text] [Related]
6. Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.
Truog WE; Pallotto E; Clark P; Banks B; Kaftan HA; Ekekezie II; Norberg M; Ballard RA
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():294S-297S. PubMed ID: 12193107
[TBL] [Abstract][Full Text] [Related]
7. Plasma thromboxane and pulmonary artery pressure in neonates treated with extracorporeal membrane oxygenation.
Bui KC; Martin G; Kammerman LA; Hammerman C; Hill V; Short BL
J Thorac Cardiovasc Surg; 1992 Jul; 104(1):124-9. PubMed ID: 1614197
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia.
de Lagausie P; de Buys-Roessingh A; Ferkdadji L; Saada J; Aisenfisz S; Martinez-Vinson C; Fund X; Cayuela JM; Peuchmaur M; Mercier JC; Berrebi D
J Pathol; 2005 Jan; 205(1):112-8. PubMed ID: 15546126
[TBL] [Abstract][Full Text] [Related]
9. Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension.
Dobyns EL; Wescott JY; Kennaugh JM; Ross MN; Stenmark KR
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):873-80. PubMed ID: 8143049
[TBL] [Abstract][Full Text] [Related]
10. The use of ECMO for persistent pulmonary hypertension of the newborn: a decade of experience.
Lazar DA; Cass DL; Olutoye OO; Welty SE; Fernandes CJ; Rycus PT; Lee TC
J Surg Res; 2012 Oct; 177(2):263-7. PubMed ID: 22901797
[TBL] [Abstract][Full Text] [Related]
11. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
[TBL] [Abstract][Full Text] [Related]
12. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure.
Sills JH; Cvetnic WG; Pietz J
J Perinatol; 1989 Mar; 9(1):43-8. PubMed ID: 2651595
[TBL] [Abstract][Full Text] [Related]
13. Persistent pulmonary hypertension of the newborn. An update.
Griffin MP
Va Med Q; 1994; 121(4):232-4. PubMed ID: 7948075
[TBL] [Abstract][Full Text] [Related]
14. Neonatal thyrotoxicosis and persistent pulmonary hypertension necessitating extracorporeal life support.
Oden J; Cheifetz IM
Pediatrics; 2005 Jan; 115(1):e105-8. PubMed ID: 15629961
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension.
Christou H; Adatia I; Van Marter LJ; Kane JW; Thompson JE; Stark AR; Wessel DL; Kourembanas S
J Pediatr; 1997 Apr; 130(4):603-11. PubMed ID: 9108859
[TBL] [Abstract][Full Text] [Related]
16. Plasma prostanoids in neonatal extracorporeal membrane oxygenation. Influence of meconium aspiration.
Bui KC; Hammerman C; Hirschl R; Snedecor SM; Cheng KJ; Chan L; Short BL; Bartlett RH
J Thorac Cardiovasc Surg; 1991 Apr; 101(4):612-7. PubMed ID: 1901122
[TBL] [Abstract][Full Text] [Related]
17. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.
Dworetz AR; Moya FR; Sabo B; Gladstone I; Gross I
Pediatrics; 1989 Jul; 84(1):1-6. PubMed ID: 2740158
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling.
Sarkar S; Barks JD; Bhagat I; Dechert R; Donn SM
Am J Perinatol; 2009 Apr; 26(4):265-70. PubMed ID: 19021092
[TBL] [Abstract][Full Text] [Related]
19. Use of extracorporeal membrane oxygenators in persistent pulmonary hypertension of the newborn.
Andrews AF; Roloff DW; Bartlett RH
Clin Perinatol; 1984 Oct; 11(3):729-35. PubMed ID: 6488675
[TBL] [Abstract][Full Text] [Related]
20. Comparison of high-frequency flow interruption ventilation and hyperventilation in persistent pulmonary hypertension of the newborn.
Jirapaet KS; Kiatchuskul P; Kolatat T; Srisuparb P
Respir Care; 2001 Jun; 46(6):586-94. PubMed ID: 11353547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
